1. Home
  2. CADL vs ESGRP Comparison

CADL vs ESGRP Comparison

Compare CADL & ESGRP Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • CADL
  • ESGRP
  • Stock Information
  • Founded
  • CADL 1999
  • ESGRP N/A
  • Country
  • CADL United States
  • ESGRP Bermuda
  • Employees
  • CADL N/A
  • ESGRP 805
  • Industry
  • CADL Biotechnology: Pharmaceutical Preparations
  • ESGRP Property-Casualty Insurers
  • Sector
  • CADL Health Care
  • ESGRP Finance
  • Exchange
  • CADL Nasdaq
  • ESGRP Nasdaq
  • Market Cap
  • CADL 185.2M
  • ESGRP N/A
  • IPO Year
  • CADL 2021
  • ESGRP N/A
  • Fundamental
  • Price
  • CADL $6.20
  • ESGRP $25.40
  • Analyst Decision
  • CADL Strong Buy
  • ESGRP
  • Analyst Count
  • CADL 1
  • ESGRP 0
  • Target Price
  • CADL $11.00
  • ESGRP N/A
  • AVG Volume (30 Days)
  • CADL 590.6K
  • ESGRP N/A
  • Earning Date
  • CADL 08-08-2024
  • ESGRP N/A
  • Dividend Yield
  • CADL N/A
  • ESGRP N/A
  • EPS Growth
  • CADL N/A
  • ESGRP N/A
  • EPS
  • CADL N/A
  • ESGRP N/A
  • Revenue
  • CADL N/A
  • ESGRP N/A
  • Revenue This Year
  • CADL N/A
  • ESGRP N/A
  • Revenue Next Year
  • CADL N/A
  • ESGRP N/A
  • P/E Ratio
  • CADL N/A
  • ESGRP N/A
  • Revenue Growth
  • CADL N/A
  • ESGRP N/A
  • 52 Week Low
  • CADL $0.66
  • ESGRP N/A
  • 52 Week High
  • CADL $14.30
  • ESGRP N/A
  • Technical
  • Relative Strength Index (RSI)
  • CADL 45.08
  • ESGRP 58.39
  • Support Level
  • CADL $5.75
  • ESGRP $25.40
  • Resistance Level
  • CADL $7.34
  • ESGRP $25.50
  • Average True Range (ATR)
  • CADL 0.50
  • ESGRP 0.11
  • MACD
  • CADL 0.12
  • ESGRP 0.02
  • Stochastic Oscillator
  • CADL 33.47
  • ESGRP 79.59

About CADL Candel Therapeutics Inc.

Candel Therapeutics Inc is a clinical-stage biopharmaceutical company focused on developing and commercializing viral immunotherapies to help patients fight cancer. The company has established two clinical-stage viral immunotherapy platforms based on novel, genetically modified adenovirus and herpes simplex virus (HSV) constructs, respectively.

About ESGRP Enstar Group Limited Depositary Shares Each Representing 1/1000th of an interest in Preference Shares

Enstar Group Ltd is a (re)insurance group that offers capital release solutions through its network of group companies. It seeks to create value by managing (re)insurance companies and portfolios of (re)insurance and other liability businesses in run-off and striving to generate an attractive risk-adjusted return from its investment portfolio. Its operations are through four reportable segments: Run-off, Assumed Life, Investments, and Legacy Underwriting.

Share on Social Networks: